Agios Pharmaceuticals, Inc. (AGIO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Agios Pharmaceuticals, Inc. (AGIO)

Go deeper and ask any question about AGIO

Company Performance

Current Price

as of Oct 03, 2024

$40.56

P/E Ratio

N/A

Market Cap

$2.31B

Description

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerAGIO
  • Price$40.56-2.94%

Trading Information

  • Market Cap$2.31B
  • Float96.94%
  • Average Daily Volume (1m)583,573
  • Average Daily Volume (3m)518,173
  • EPS-$6.49

Company

  • Revenue$31.31M
  • Rev Growth (1yr)28.35%
  • Net Income-$96.12M
  • Gross Margin64.16%
  • EBITDA Margin-1,209.80%
  • EBITDA-$104.22M
  • EV$1.94B
  • EV/Revenue62.10
  • P/EN/A
  • P/S73.59